Project Number EUJPND-Belgium-FIE-Thera Neuropharma Europe bvba-292 Agency/Funding Organization Flanders Innovation & Entrepreneurship Funding Year 2016 View Full Project Details for TherALS-1 : Characterisation of novel small molecule regenerative compounds for the treatment of amyotrophic lateral sclerosis Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category H. Brain Aging and Common Mechanisms related to Dementia 2. Common Mechanisms Related to Dementias b. Translational Research Researcher and Organization Principal Investigator Thera Neuropharma Europe bvba Principal Investigator First Name Thera Neuropharma Europe bvba Principal Investigator Last Name Thera Neuropharma Europe bvba Awardee Organization Thera Neuropharma Europe bvba Contact PI Country Belgium Project Detail FY Overall Cost $560,562 Funding Organization Agency/Funding Organization Flanders Innovation & Entrepreneurship Funding Organization Country Belgium Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
